tretinoin and Eye-Burns

tretinoin has been researched along with Eye-Burns* in 3 studies

Reviews

1 review(s) available for tretinoin and Eye-Burns

ArticleYear
Inflammatory mechanisms in corneal ulceration.
    Transactions of the American Ophthalmological Society, 1985, Volume: 83

    Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Aged; Animals; Child; Cholera Toxin; Colchicine; Cornea; Corneal Ulcer; Cyanoacrylates; Epithelium; Eye Burns; Female; Fibronectins; Flurbiprofen; Guinea Pigs; Humans; Immunosuppressive Agents; Male; Middle Aged; Rabbits; Rats; Retinoids; Tears; Tissue Adhesives; Tretinoin

1985

Other Studies

2 other study(ies) available for tretinoin and Eye-Burns

ArticleYear
Canonical NF-κB signaling maintains corneal epithelial integrity and prevents corneal aging via retinoic acid.
    eLife, 2021, 06-04, Volume: 10

    Disorders of the transparent cornea affect millions of people worldwide. However, how to maintain and/or regenerate this organ remains unclear. Here, we show that

    Topics: Age Factors; Aldehyde Dehydrogenase 1 Family; Animals; Burns, Chemical; Cell Differentiation; Cell Proliferation; Cells, Cultured; Cellular Senescence; Corneal Neovascularization; Corneal Stroma; Disease Models, Animal; Epithelium, Corneal; Eye Burns; Mice, Knockout; Regeneration; Retinal Dehydrogenase; Signal Transduction; Stem Cells; Transcription Factor RelA; Tretinoin

2021
Retinoic Acid Engineered Amniotic Membrane Used as Graft or Homogenate: Positive Effects on Corneal Alkali Burns.
    Investigative ophthalmology & visual science, 2017, 07-01, Volume: 58, Issue:9

    Alkali burns are the most common, severe chemical ocular injuries, their functional prognosis depending on corneal wound healing efficiency. The purpose of our study was to compare the benefits of amniotic membrane (AM) grafts and homogenates for wound healing in the presence or absence of previous all-trans retinoic acid (atRA) treatment.. Fifty male CD1 mice with reproducible corneal chemical burn were divided into five groups, as follows: group 1 was treated with saline solution; groups 2 and 3 received untreated AM grafts or grafts treated with atRA, respectively; and groups 4 and 5 received untreated AM homogenates or homogenates treated with atRA, respectively. After 7 days of treatment, ulcer area and depth were measured, and vascular endothelial growth factor (VEGF) and matrix metalloproteinase 9 (MMP-9) were quantified.. AM induction by atRA was confirmed via quantification of retinoic acid receptor β (RARβ), a well-established retinoic acid-induced gene. Significant improvements of corneal wound healing in terms of ulcer area and depth were obtained with both strategies. No major differences were found between the efficiency of AM homogenates and grafts. This positive action was increased when AM was pretreated with atRA. Furthermore, AM induced a decrease in VEGF and MMP-9 levels during the wound healing process. The atRA treatment led to an even greater decrease in the expression of both proteins.. Amnion homogenate is as effective as AM grafts in promoting corneal wound healing in a mouse model. A higher positive effect was obtained with atRA treatment.

    Topics: Alkalies; Amnion; Animals; Burns, Chemical; Corneal Ulcer; Disease Models, Animal; Eye Burns; Fluorescent Antibody Technique, Indirect; Humans; Keratolytic Agents; Male; Matrix Metalloproteinase 9; Mice; Tissue Engineering; Transplants; Tretinoin; Vascular Endothelial Growth Factor A; Wound Healing

2017